🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
GlaxoSmithKline
-6.64%
Pharma / Pharma and biotechnology
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | Web1. Fluctuating market conditions: The fluctuations in market conditions can impact the stock value of GlaxoSmithKline, making it vulnerable to potential losses.
2. Competition: GSK faces a lot of competition, particularly from large generic drug companies. This can lead to pricing pressures and reduced profit margins.
3. Potential Litigation: GSK has been involved in a number of legal disputes in the past. These legal proceedings can be costly and cause reputational damage.
4. Product Recall Risks: Due to manufacturing defects or possible product contamination, GSK faces potential risks of product recalls. This can lead to financial and reputational losses.
5. Regulatory Uncertainty: Changes in regulations and laws can have a significant impact on GSK’s ability to market and distribute its products. This can significantly affect its profitability.
Wait! There's more — sign up for free or log in